FCF YoY
+22.13%
OCF YoY
+11.33%
Capex YoY
-42.72%
FCF Conversion Δ
+8.1 pp
Free cash flow bridge for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $48.8M
FCF bridge breakdown for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $221M | — |
| Operating Cash Flow | $30M | +61.4% |
| Capital Expenditure | $18.8M | +38.6% |
| Free Cash Flow | $270M | — |
- Prior Free Cash Flow$221M
- Operating Cash Flow$30M
- Capital Expenditure$18.8M
- Free Cash Flow$270M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.23% TTM
- Dividend Profile0.45% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.